Johnson & Johnson (NYSE:JNJ) Appoints New McNeil Head

Johnson & Johnson (NYSE:JNJ) has appointed Denice Torres as the head of its McNeil consumer unit. Johnson & Johnson (NYSE:JNJ) Appoints New McNeil Head Johnson & Johnson (NYSE:JNJ) has announced that it has named Denice Torres, an executive from its pharmaceuticals division, to head its McNeil Consumer division. Torres will have to report to Pat Mutchler, who was named as the group chairman of a newly created division within McNeil focused on Tylenol, Motrin and other over-the-counter drugs. A Johnson & Johnson (NYSE:JNJ) spokeswoman has confirmed the appointment, and that she will take her post on April 25. Johnson & Johnson (NYSE:JNJ) shares were at 59.46 at the end of the last day’s trading. There’s been a -5.0% movement in the stock price over the past 3 months. Johnson & Johnson (NYSE:JNJ) Analyst Advice Consensus Opinion: Hold Mean recommendation: 2.27 (1=Strong Buy, 5=Strong Sell) 3 Months Ago: 1.96 Zack’s Rank: 14 out of 15 in the industry
Negocioenlinea
tdp2664
E money daily